ScoreWhy is Avanos Medical, Inc. ?
1
Poor Management Efficiency with a low ROCE of 5.39%
- The company has been able to generate a Return on Capital Employed (avg) of 5.39% signifying low profitability per unit of total capital (equity and debt)
2
Poor long term growth as Net Sales has grown by an annual rate of -0.37% over the last 5 years
3
Flat results in Jun 25
- ROCE(HY) Lowest at -46.17%
- RAW MATERIAL COST(Y) Grown by 5.58% (YoY)
- OPERATING PROFIT MARGIN(Q) Lowest at 9.89 %
4
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -36.70%, its profits have risen by 75.2% ; the PEG ratio of the company is 0.1
5
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -36.70% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Avanos Medical, Inc. for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Avanos Medical, Inc.
106.46%
-1.02
38.02%
S&P 500
25.41%
0.70
20.15%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-0.38%
EBIT Growth (5y)
-19.16%
EBIT to Interest (avg)
7.55
Debt to EBITDA (avg)
0.93
Net Debt to Equity (avg)
0.02
Sales to Capital Employed (avg)
0.62
Tax Ratio
3.77%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
5.39%
ROE (avg)
4.86%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
32
Industry P/E
Price to Book Value
0.81
EV to EBIT
21.76
EV to EBITDA
9.46
EV to Capital Employed
0.82
EV to Sales
0.93
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
3.75%
ROE (Latest)
2.50%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Bullish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend7What is working for the Company
INVENTORY TURNOVER RATIO(HY)
Highest at 2.64 times
NET SALES(Q)
Highest at USD 182.2 MM
INTEREST COVERAGE RATIO(Q)
Highest at 1,493.33
DEBTORS TURNOVER RATIO(HY)
Highest at 6.89 times
-10What is not working for the Company
NET PROFIT(HY)
At USD 3.21 MM has Grown at -92.9%
RAW MATERIAL COST(Y)
Grown by 9.67% (YoY
CASH AND EQV(HY)
Lowest at USD 155.4 MM
Here's what is working for Avanos Medical, Inc.
Net Sales
Highest at USD 182.2 MM and Grown
In each period in the last five periodsMOJO Watch
Near term sales trend is very positive
Net Sales (USD MM)
Interest Coverage Ratio
Highest at 1,493.33
in the last five periodsMOJO Watch
The company's ability to manage interest payments is improving
Operating Profit to Interest
Inventory Turnover Ratio
Highest at 2.64 times and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Debtors Turnover Ratio
Highest at 6.89 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Depreciation
Highest at USD 10.2 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (USD MM)
Here's what is not working for Avanos Medical, Inc.
Net Profit
At USD 3.21 MM has Grown at -92.9%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
Cash and Eqv
Lowest at USD 155.4 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Raw Material Cost
Grown by 9.67% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
